These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4624843)

  • 61. Gout masquerading as a triquetral fracture.
    Kortan N; Roberts J; Roebuck J
    J Rheumatol; 2010 Mar; 37(3):670-1. PubMed ID: 20197566
    [No Abstract]   [Full Text] [Related]  

  • 62. [Therapy of gout in surgical patients].
    Koch G; Schlosser GA
    Med Klin; 1968 Nov; 63(47):1897-9. PubMed ID: 5712110
    [No Abstract]   [Full Text] [Related]  

  • 63. On call. I've had gout for many years. I used to take Zyloprim without any problems, but I just had a severe allergic reaction, so my doctor switched me to Benemid. I'm doing okay, but the drug sometimes upsets my stomach. Do you have any suggestions?
    Simon HB
    Harv Mens Health Watch; 2010 Jan; 14(6):7-8. PubMed ID: 20464796
    [No Abstract]   [Full Text] [Related]  

  • 64. Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia.
    Stamp LK; Turner R; Khalilova IS; Zhang M; Drake J; Forbes LV; Kettle AJ
    Rheumatology (Oxford); 2014 Nov; 53(11):1958-65. PubMed ID: 24899662
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An optimal ultrasonographic diagnostic test for early gout: A prospective controlled study.
    Norkuviene E; Petraitis M; Apanaviciene I; Virviciute D; Baranauskaite A
    J Int Med Res; 2017 Aug; 45(4):1417-1429. PubMed ID: 28617199
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Radiologic differential diagnosis of inflammatory rheumatic diseases preferably located in peripheral joints].
    Schacherl M
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:67-8. PubMed ID: 4344600
    [No Abstract]   [Full Text] [Related]  

  • 68. [Serum and urine uric acid content in hemoblastoses and gout as well as its modification by allopurinol].
    Helbig W; Findeisen B
    Z Gesamte Inn Med; 1971 Apr; 26(7):233-7. PubMed ID: 5285596
    [No Abstract]   [Full Text] [Related]  

  • 69. The influence of allopurinol on the course of gout. A study of 28 cases.
    Kawenoki-Minc E; Eyman E; Sopata I; Weryńska-Przybylska J
    Reumatologia; 1970; 8(3):177-92. PubMed ID: 5469423
    [No Abstract]   [Full Text] [Related]  

  • 70. The effect of control and self-medication of chronic gout in a developing country. Outcome after 10 years.
    Darmawan J; Rasker JJ; Nuralim H
    J Rheumatol; 2003 Nov; 30(11):2437-43. PubMed ID: 14677190
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of benzbromarone and allopurinol on adiponectin in vivo and in vitro.
    Inokuchi T; Tsutsumi Z; Takahashi S; Ka T; Yamamoto A; Moriwaki Y; Masuzaki H; Yamamoto T
    Horm Metab Res; 2009 Apr; 41(4):327-32. PubMed ID: 19048458
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of newly available febuxostat in a case of chronic tophaceous gout contraindicated to allopurinol and probenecid.
    Hilmi BA; Asmahan MI; Rosman A
    Med J Malaysia; 2012 Feb; 67(1):125-6. PubMed ID: 22582566
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Allopurinol-associated hand and foot deformities in chronic tophaceous gout.
    Gottlieb NL; Gray RG
    JAMA; 1977 Oct; 238(15):1663-4. PubMed ID: 578255
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Preservation of renal function during gout treatment with febuxostat: a quantitative study.
    Whelton A; MacDonald PA; Chefo S; Gunawardhana L
    Postgrad Med; 2013 Jan; 125(1):106-14. PubMed ID: 23391676
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Mechanism of the action of allopurinol].
    Pikhlak EG; Piliaev VG
    Sov Med; 1981; (10):111-4. PubMed ID: 7031905
    [No Abstract]   [Full Text] [Related]  

  • 76. [How to treat hyperuricemia and gout attacks in compensated kidney failure?].
    Gröbner W
    Dtsch Med Wochenschr; 2002 Mar; 127(11):576. PubMed ID: 11894180
    [No Abstract]   [Full Text] [Related]  

  • 77. Treatment of gout.
    Cohen MG
    Intern Med J; 2011 Jan; 41(1a):70-1. PubMed ID: 21265967
    [No Abstract]   [Full Text] [Related]  

  • 78. A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia.
    Xu S; Liu X; Ming J; Chen S; Wang Y; Liu X; Liu H; Peng Y; Wang J; Lin J; Ji H; Liu B; Lu Y; Liu P; Zhang Y; Ji Q
    Int J Rheum Dis; 2015 Jul; 18(6):669-78. PubMed ID: 26013187
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists.
    Vargas-Santos AB; Castelar-Pinheiro Gda R; Coutinho ES; Schumacher HR; Singh JA; Schlesinger N
    PLoS One; 2015; 10(8):e0135805. PubMed ID: 26274585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.